2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2006
November 20, 2006
Aegera Therapeutics Announces First Close of Series C Funding
March 28, 2006
Aegera Therapeutics Inc. appoints Dr. Michael J. Berendt as President and Chief Executive Officer
February 28, 2006
New publication on AEG3482 – a broad base neuroprotectant
February 15, 2006
Aegera initiates third clinical trial for AEG35156 – a targeted therapeutic for oncology
January 09, 2006
Aegera receives approval from Health Canada to initiate a phase I clinical trial for AEG33783 – a drug designed to treat peripheral neuropathies
About Aegera
|
Pipeline
|
Clinical Trials
|
Partnerships
|
Media
|
Careers
|
Contact Us
|
Français
© 2010 Aegera Therapeutics Inc. All rights reserved. Developed by
Grafika Designs
.
